Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shenzhen YHLO Biotech CoSHSE:688575 +1.17%70 OCF Yield % is 9.27 as of Aug. 10, 2026, which is 94% above its 10-year median of 4.78. GuruFocus rates SHSE:688575 with a GF Score™ of 70/100 and a GF Value™ of ¥12.86 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 848 Medical Devices & Instruments companies, Shenzhen YHLO Biotech Co ranks better than 85.61% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Shenzhen YHLO Biotech Co's OCF Yield % or its related term are showing as below:
SHSE:688575'
s OCF Yield % Range Over the Past 10 Years
Min: -0.6 Med: 4.78 Max: 14.84
Current: 9.27
During the past 9 years, the highest OCF Yield % of Shenzhen YHLO Biotech Co was 14.84%. The lowest was -0.60%. And the median was 4.78%.
SHSE:688575's OCF Yield % is ranked better than 85.61% of 848
companies
in the Medical Devices & Instruments industry
Industry Median: 1.57
vs SHSE:688575: 9.27
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Shenzhen YHLO Biotech Co OCF Yield % Related Terms
Shenzhen YHLO Biotech Co OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688575 vs ABT, SYK, MDT: OCF Yield % Comparison
For the Medical Devices subindustry, Shenzhen YHLO Biotech Co's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shenzhen YHLO Biotech Co OCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shenzhen YHLO Biotech Co's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Shenzhen YHLO Biotech Co's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shenzhen YHLO Biotech Co (SHSE:688575) has a OCF Yield % of 9.27 as of Aug. 10, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Shenzhen YHLO Biotech Co and its competitors. This is 94% above median its historical median of 4.78. According to the industry distribution chart, Shenzhen YHLO Biotech Co ranks #122 out of 848 companies in the Medical Devices & Instruments industry, placing it in the top 14.4%.
Is Shenzhen YHLO Biotech Co's OCF Yield % too high?
Shenzhen YHLO Biotech Co's current OCF Yield % of 9.27 is 94% above median its 10-year median of 4.78. The Medical Devices & Instruments industry median OCF Yield % is 1.57. Shenzhen YHLO Biotech Co's value of 9.27 is 490.4% above this industry median. Based on the distribution chart, Shenzhen YHLO Biotech Co ranks #122 out of 848 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Shenzhen YHLO Biotech Co has a GF Score™ of 70/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shenzhen YHLO Biotech Co's OCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shenzhen YHLO Biotech Co ranks #122 out of 848 companies for OCF Yield %. This places Shenzhen YHLO Biotech Co in the top 14% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 1.57. Shenzhen YHLO Biotech Co's value of 9.27 is 490.4% above this benchmark. While the company's 10-year median is 4.78 vs. the industry median of 1.57, Shenzhen YHLO Biotech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.57, based on 848 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shenzhen YHLO Biotech Co's current OCF Yield % of 9.27 is 490.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Shenzhen YHLO Biotech Co and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shenzhen YHLO Biotech Co's current OCF Yield % is 9.27, which is 94% above median its own 10-year median of 4.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shenzhen YHLO Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Shenzhen YHLO Biotech Co (SHSE:688575) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥12.86, compared to a current price of ¥9.55 — trading 25.7% below its estimated fair value. The current OCF Yield % is 9.27, which is 94% above median its 10-year median of 4.78 and 490.4% above the Medical Devices & Instruments industry median of 1.57. Shenzhen YHLO Biotech Co's overall GF Score™ is 70/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Shenzhen YHLO Biotech Co (SHSE:688575), the current OCF Yield % is 9.27 as of Aug. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shenzhen YHLO Biotech Co (SHSE:688575) Overvalued in 2026?
Based on GuruFocus' analysis, Shenzhen YHLO Biotech Co stock appears to be undervalued.
The current stock price of ¥9.55 is trading 25.7% below its estimated GF Value™ of ¥12.86.
GuruFocus considers Shenzhen YHLO Biotech Co to be Modestly Undervalued.
Key valuation signals for SHSE:688575:
OCF Yield %: 9.27 (94% above median its 10-year median of 4.78)
GF Value™: ¥12.86 vs. price of ¥9.55 (25.7% below fair value)
Industry Position: 490.4% above the Medical Devices & Instruments median (#122 of 848)
No single metric tells the full story. See the SHSE:688575 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shenzhen YHLO Biotech Co Ltd is engaged in the research, development, production and sales of in vitro diagnostic instruments and supporting reagents based on chemiluminescence immunoassay. Its product portfolio includes solutions based on technologies such as chemiluminescence, biochemistry, indirect immunofluorescence, immunoblotting, fluorescent immunochromatography, and colloidal gold immunochromatography. Its products are used in diagnostic applications including autoimmunity, reproductive health, infection, liver disease, and respiratory disease testing, and are supplied to healthcare institutions and testing centers.
70GF Score
Get the complete analysis for SHSE:688575
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688575 has been successfully added to your 
